PAPER Kmet O, Filipets N, Kmet T, Hrachova T, Vepriuk Y

ENALAPRIL EFFECT ON GLUTATHIONE CHAIN OF THE ANTIOXIDANT SYSTEM OF THE BRAIN IN RATS WITH SCOPOLAMINE-INDUCED NEURODEGENERATION.

Georgian Med News. 2019 Jun;(291):97-101. PubMed: 31418740

PAPER Sjögren M, Soylu-Kucharz R, Dandunna U, Stan TL, Cavalera M, Sandelius Å, Zetterberg H, Björkqvist M

Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.

Neurobiol Dis. 2019 Dec;132:104560. Epub 2019 Aug 13 PubMed: 31419548

PAPER Giorgi FS, Saccaro LF, Galgani A, Busceti CL, Biagioni F, Frati A, Fornai F

The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer's disease.

Brain Res Bull. 2019 Nov;153:47-58. Epub 2019 Aug 13 PubMed: 31419539

PAPER Glynn K, Coen R, Lawlor BA

Is the Quick Mild Cognitive Impairment Screen (QMCI) more accurate at detecting mild cognitive impairment than existing short cognitive screening tests? A systematic review of the current literature.

Int J Geriatr Psychiatry. 2019 Dec;34(12):1739-1746. Epub 2019 Aug 22 PubMed: 31418473

PAPER Hayden KM, Gaussoin SA, Hunter JC, Manson JE, Sachs BC, Shadyab AH, Tindle HA, Mossavar-Rahmani Y, Mozhui K, Snively BM, Rapp SR, Resnick SM

Cognitive resilience among APOE ε4 carriers in the oldest old.

Int J Geriatr Psychiatry. 2019 Dec;34(12):1833-1844. Epub 2019 Aug 22 PubMed: 31418472

PAPER Wanker EE, Ast A, Schindler F, Trepte P, Schnoegl S

The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.

J Neurochem. 2019 Nov;151(4):507-519. Epub 2019 Sep 15 PubMed: 31418858

PAPER Lanthier C, Payan H, Liparulo I, Hatat B, Lecoutey C, Since M, Davis A, Bergamini C, Claeysen S, Dallemagne P, Bolognesi ML, Rochais C

Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease.

Eur J Med Chem. 2019 Nov 15;182:111596. Epub 2019 Aug 6 PubMed: 31419776

PAPER Utianski RL, Botha H, Martin PR, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Butts AM, Lowe VJ, Jack CR Jr, Senjem ML, Spychalla AJ, Whitwell JL, Josephs KA

Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia.

Brain Lang. 2019 Oct;197:104676. Epub 2019 Aug 13 PubMed: 31419589

PAPER Chan JC, Stout JC, Vogel AP

Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.

Neurosci Biobehav Rev. 2019 Dec;107:450-460. Epub 2019 Aug 13 PubMed: 31419452

PAPER Cox LM, Abou-El-Hassan H, Maghzi AH, Vincentini J, Weiner HL

The sex-specific interaction of the microbiome in neurodegenerative diseases.

Brain Res. 2019 Dec 1;1724:146385. Epub 2019 Aug 13 PubMed: 31419428

PAPER Kwart D, Gregg A, Scheckel C, Murphy EA, Paquet D, Duffield M, Fak J, Olsen O, Darnell RB, Tessier-Lavigne M

A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.

Neuron. 2019 Oct 23;104(2):256-270.e5. Epub 2019 Aug 12 PubMed: 31416668

The Tau Pipeline Enabling Program (T-PEP)

GRANT Saturday, August 17, 2019- 20:45 Alzheimer's Association and Tau Consortium Up to $750,000 LOI Deadline: September 12, 2019, 5 p.m. ET The Tau Pipeline Enabling Program (T-PEP) ...

PAPER TCW J, Liang SA, Qian L, Pipalia NH, Chao MJ, Shi Y, Bertelsen SE, Kapoor M, Marcora E, Sikora E, Holtzman DM, Maxfield FR, Zhang B, Wang M, Poon WW, Goate AM

Cholesterol and matrisome pathways dysregulated in human APOE ε4 glia

bioRχiv, July 25, 2019

Larry Yu

Kansas City, United States

Tenure-Track Faculty Positions in Neuroscience

JOB 2019-08-17 Employer University of Maryland School of Medicine Contact Candidates should submit the following as a single PDF to  facsearch@umaryland.edu: Curriculum vitae, brief statement of research interests and goals, and contact information for three references. ...